<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35167046</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2240-2993</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Acta neurologica Belgica</Title><ISOAbbreviation>Acta Neurol Belg</ISOAbbreviation></Journal><ArticleTitle>Myasthenia gravis with amyotrophic lateral sclerosis with positive anti-Hu antibody: a rare co-existence.</ArticleTitle><Pagination><StartPage>315</StartPage><EndPage>317</EndPage><MedlinePgn>315-317</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13760-022-01894-4</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Neurological Department of the First Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatric Neurological Department of the Second Medical Center &amp; National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongfen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Neurological Department of the First Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yanran</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Neurological Department of the First Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Zhengqing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Neurological Department of the First Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xusheng</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-2451-0254</Identifier><AffiliationInfo><Affiliation>Neurological Department of the First Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, 100853, China. lewish301@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Acta Neurol Belg</MedlineTA><NlmUniqueID>0247035</NlmUniqueID><ISSNLinking>0300-9009</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011950">Receptors, Cholinergic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009157" MajorTopicYN="Y">Myasthenia Gravis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011950" MajorTopicYN="N">Receptors, Cholinergic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>12</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35167046</ArticleId><ArticleId IdType="doi">10.1007/s13760-022-01894-4</ArticleId><ArticleId IdType="pii">10.1007/s13760-022-01894-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dumansky YV, Syniachenko OV, Stepko PA et al (2018) Paraneoplastic syndrome in lung cancer. Exp Oncol 40(3):239&#x2013;242</Citation><ArticleIdList><ArticleId IdType="doi">10.31768/2312-8852.2018.40(3):239-242</ArticleId><ArticleId IdType="pubmed">30285007</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai H, Cui L, Guan Y et al (2017) Amyotrophic lateral sclerosis and Myasthenia gravis overlap syndrome: a review of two cases and the associated literature. Front Neurol 8:1&#x2013;8</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00218</ArticleId></ArticleIdList></Reference><Reference><Citation>de Pasqua S, Cavallieri F, D&#x2019;Angelo R et al (2017) Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence? Neurol Sci 38(3):441&#x2013;444</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-016-2787-3</ArticleId><ArticleId IdType="pubmed">27913903</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Mar AM, Vandenberghe N, Berhoune N et al (2016) Unusual association of amyotrophiclateral sclerosis and myasthenia gravis: a dysregulation of the adaptive immune system? Neuromuscul Disord 26(6):342&#x2013;346</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2016.03.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Goldacre R, Ramagopalan S et al (2013) Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology 81(14):1222&#x2013;1225</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a6cc13</ArticleId><ArticleId IdType="pubmed">23946298</ArticleId><ArticleId IdType="pmc">3795611</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Gordon PH, Camdessanche JP (2015) Is there a paraneoplastic ALS? Amyotroph Lateral Scler Frontotemporal Degener 16(3&#x2013;4):252&#x2013;257</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.965178</ArticleId><ArticleId IdType="pubmed">25285651</ArticleId></ArticleIdList></Reference><Reference><Citation>Arneth BM (2019) Neuronal antibodies and associated syndromes. Autoimmune Dis 2019:2135423</Citation><ArticleIdList><ArticleId IdType="pubmed">31380113</ArticleId><ArticleId IdType="pmc">6652068</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>